0001179110-19-013163.txt : 20191227 0001179110-19-013163.hdr.sgml : 20191227 20191227165904 ACCESSION NUMBER: 0001179110-19-013163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191224 FILED AS OF DATE: 20191227 DATE AS OF CHANGE: 20191227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manning Anthony M. CENTRAL INDEX KEY: 0001716468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 191314062 MAIL ADDRESS: STREET 1: C/O PALATIN TECHNOLOGIES, INC. STREET 2: 4B CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2019-12-24 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001716468 Manning Anthony M. C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Common Stock 2019-12-24 4 M 0 28437 12.58 A 33880 D Common Stock 2019-12-24 4 M 0 16258 13.02 A 50138 D Common Stock 2019-12-24 4 M 0 6750 10.83 A 56888 D Common Stock 2019-12-24 4 S 0 51445 20.00 D 5443 D Stock Option(Right to Buy) 12.58 2019-12-24 4 M 0 12451 0 D 2016-11-19 2023-02-19 Common Stock 12451 0 D Stock Option(Right to Buy) 13.02 2019-12-24 4 M 0 14804 0 D 2018-02-18 2025-02-18 Common Stock 14804 73 D Stock Option (Right to Buy) 13.02 2019-12-24 4 M 0 1454 0 D 2018-02-18 2025-02-18 Common Stock 1454 5841 D Stock Option(Right to Buy) 12.58 2019-12-24 4 M 0 15986 0 D 2017-02-19 2025-05-20 Common Stock 15986 0 D Stock Option (Right to Buy) 10.83 2019-12-24 4 M 0 6750 0 D 2018-05-09 2026-02-09 Common Stock 6750 1499 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person December 14, 2018. /s/ R. Mark Chamberlin as attorney in fact 2019-12-27